mRNA |
BMS-708163 |
GDSC1000 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
KIN001-236 |
GDSC1000 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
MLN2480 |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.7 |
mRNA |
BRD-K48334597 |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.7 |
mRNA |
BRD-K64610608 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |